KIDRON NADAV (President and CEO) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2026ACC: 0001213900-26-031013
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
+167K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
167K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+167K
Price / share
—
Trade value
—
% of position
5.1%
3/17/2026
3.26M→3.42M
Total
Net shares
+167K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | A · Award | +167K | — | — | 5.1% | 3.26M | 3.42M |
| Total | +167K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported